Search


Search Parameters








1 - 15 of 15 items
Four words regarding clinical trials: science/profit, risks/benefits Open Access

Pills for profits. The transformation of the pharmaceutical industry Open Access
Antonio Ugalde, Núria Homedes

Two more words regarding clinical trials: deception/truth, the moral anemia of Big Pharma Open Access

Transformations in the management of diabetes: an analysis of the scientific evidence published by two scientific societies (1980-2010) Open Access
Mónica Serena Perner

Questioning clinical trials Open Access

Scientific advances and moral progress: the end does not justify the means Open Access
Juan Carlos Tealdi

Clinical research in Latin America and Argentina: time for a change? Open Access

Toward independent clinical trials in Latin America. Comments on "Four words regarding clinical trials" Open Access

Authors' response Open Access

Four other keywords to critically analyze a clinical trial: hypothesis, implementation, analysis and publication Open Access

Clinical trials, the State and society: where does science end and profit-making begin? Open Access

Commentary on the article “Bioethical problems in researching new vaccines: Do they respond to public health reasons?” Open Access
Alejandro Ellis

The sustainability of the health system and the pharmaceutical market: A permanent interaction between the cost of medications, the patent system, and disease care Open Access
Tomás Gómez Franco, Eva Matarín Rodríguez-Peral, Francisco García García

Globalization and medical identities in clinical trials Open Access
Medardo Ávila Vázquez

The use of placebos in phase III clinical trials in Brazil Open Access
Gustavo Butzge Rubenich, Stephanie Tomasi Heck, Fernando Hellmann, Bruno Rodolfo Schlemper Junior

1 - 15 of 15 items